FDA Investigator Todd M Stankewicz

Todd M Stankewicz has inspections in 2 countries as of 18 Oct 2023. Todd M Stankewicz has collaborated with a combinined 3859 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
56
Last Inspection Date:
18 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, India
Co-Investigator(s):
Adam J Taylor, Ademola O Daramola, Aditi S Thakur, Alan P Kurtzberg, Alicia M Mozzachio, Amanda Dinaro, Amanda S Zorn, Ana E Morales, Ana L Kewes, Andrew A Leboeuf, Ann Marie Montemurro, Ann Marie Schofield, Anna Flynn, Anthony F Lorenzo, Anthony R Ronga, Arsen Karapetyan, Ashley L Reiber, Audrey Dela Cruz, Barry Cherney, PhD, Brentley S Collins, Brian D Nicholson, Brian P Emanuel, Brittani N Franklin, Brittany R Laymon, Bruce H Mccullough, Bryan L Mcguckin, Burnell M Henry, Carla J Lundi, Carlyn L Ray, Carrie Ann Plucinski, CDR Ileana Barreto Pettit, CDR Sean T Creighton, Chad E Schmear, Chad J Whitwell, Charlie P Booker, Chase S Baldwin, Cheryl A Kmiec, Chiang Syin, PhD, Christina A Miller, Christina V Santos, Christopher B Harding, Christopher D Leach, Clotia Cabbey Mensah, Daniel B Arrecis, Daniel C Kearns, Daniel J Brown, Daniel Kearns, Dariusz Galezowski, Darrell E Luedtke, David J Gasparovich, David Perkins, Dawnna D Brown, Debra Boyd Seale, Debra I Love, Debra L Boyd Seale, Denarvis C Mendenhall, Denise L Burosh, Dr. Gang Wang, PhD, Dr. Guang Gao, PhD, Edwardstine J Reese, Elliot P Cowam, PhD, Emilie E Kahn, Eric M Mueller, PharmD, Eric S Pittman, Gene D Arcy, Gregory R Dill, Harperd, Helen B Ricalde, Humera Khan, Humera T Khan, Insook Son, Ivis Lnegron Torres, Jacqueline Mdiaz Albertini, James E Roberts, James L Finn, James P Duggan, James W Placinski, James W Plucinski, Jan B Welch, Jan Welch, Jason F Chancey, Jayne E Holcomb, Jeanne J Chiu, Jeanne J Thai, Jeanne M Morris, Jennifer C Adams, Jennifer C Johnson, Jesse A Vazquez, Jessica L Burley, Joan A Loreng, Jocelyn C Turner, John A Iwen, John M Seale, Jose Acruz Gonzalez, Joseph A Morkunas, Joseph D Cooper, Joshua J Silvestri, Joshua M Adams, Julie D Bringger, Junho Pak, Justin A Boyd, Justin R Hays, Karen E Masley, Karen Emasley Joseph, Karen Emaslwey Joseph, Katherine D Adams, Kathleen B Swat, Kathleen S Tormey, Kham Phommachanh, Kimberly Lewandowski Walker, Kristen E Szenderski, Kujtim Sadiku, Kyran R Gibson, Lagurta M Mayher, Lakisha M Williams, Lana K Waselewski, Latoya A Griffith, Lauren A Crivellone, Laurie A Haxel, Lawrence J Stringer, Lawrence R Terando, Leeterry Moore, Lequita M Mayhew, Lesley Maep Lutao, Leslie D Hintz, Liliya V Bubiy, Linda F Murphy, Lisa A Warner, Lisa C Lewis, Lisa Hayka, Lisa Hornback, Lisa M Bellows, Lisa M Feola, Lorelei S Jarrell, Maksim A Levenchuk, Margaret Mtorres Vazquez, Margaret Torres Vazquez, Maria Diaz, Mark E Frank, Mark I Kaspar, Martha T Olone, Maureen C Melvin, Michael A Charles, Michael D Robinson, Michael E Maselli, Michele L Glendenning, Mihaly S Ligmond, Nancy J Lucas, Nibin Varghese, MS, Nicholas F Lyons, Nicholas J Presto, Nicholas P Diorio, Nicholas Z Lu, Nicole J Clausen, Nicole K Trudel, Nicole S Williams, Norman L Brown, Norman Wong, Omotunde O Osunsanmi, Pablo Alcantara, Paola S Barnett, Parul M Patel, Patricia A Mcilroy, Patrick C Klotzbuecher, Patrick E Gainer, Paula A Trost, Paula P Demichael, Peter E Baker, Peterson, Phung Thien Nguyen, Prabhu P Raju, Rachel C Harrington, Rachel T Evans, Rafael Padilla, Ralph A Erickson, Rebecca K Olin, Renee L Anderson, Robert D Tollefsen, Robert L Stevenson, Roberta W Cunningham, Rona Leblanc, PhD, Rose M Ashley, Rosemary A Sexton, Roshni J Patel, Russ R Rivy, Russell K Riley, Sandra A Boyd, Sarah B Tanksley, Sarah E Rhoades, Sean P Ryan, Shana L Williams, Simone E Pitts, Sixto M Mercado Rios, State Agency, Stefen D Mcmillan, Stephanie A Wright, Stephen D Eich, Sudha Shukla, Sullan, Susan A Zullo, PhD, Susan M Jackson, Susan P Bruederle, Susan W Ciani, Tamara Brey, Tara A Marshall, Tara C Alcazar, That Q Dang, Thomas J Arista, Thomas W Nojek, Thunder N Dunkijacobs, Travis S Bradley, Uruaku A Obasi, Vioela J Caze, William D Sherman, William G Nelson, William R Weissinger, Youkeun Kim, Yvonne E Lozano, Zerita White, Zoey A Trombley

Todd M Stankewicz's Documents

Publish Date Document Type Title
April, 2003 FDA 483 Beutlich Pharmaceuticals, LLC - Form 483, 2003-04-07
February, 2004 FDA 483 AbbVie Inc. - Form 483, 2004-02-17
May, 2003 FDA 483 Hospira, Inc. - Form 483, 2003-05-01
April, 2002 EIR Baxter Healthcare Corporation - EIR, 2002-02-11
September, 2002 EIR Kaltron, Inc.; d.b.a. Kaltron-Pettibone - EIR, 2002-09-23
September, 2003 FDA 483 Response AbbVie Inc. - Form 483R, 2003-10-16
September, 2003 EIR AbbVie Inc. - EIR, 2003-09-26
February, 2003 FDA 483 Hospira, Inc. - Form 483, 2003-02-26
April, 2003 FDA 483 Response Beutlich Pharmaceuticals, LLC - Form 483R, 2003-04-17
September, 2003 FDA 483 Hospira, Inc. - Form 483, 2003-09-02
April, 2003 EIR Beutlich Pharmaceuticals, LLC - EIR, 2003-04-07
March, 2003 EIR AbbVie Inc. - EIR, 2003-03-28
May, 2003 FDA 483 Response Hospira, Inc. - Form 483R, 2003-05-23
March, 2003 FDA 483 Response AbbVie Inc. - Form 483R, 2003-04-17
April, 2002 FDA 483 Response Baxter Healthcare Corporation - Form 483R, 2002-03-01
April, 2006 FDA 483 GLAND PHARMA LIMITED - Form 483, 2006-04-18
March, 2003 FDA 483 AbbVie Inc. - Form 483, 2003-03-28
February, 2004 FDA 483 Response AbbVie Inc. - Form 483R, 2004-03-03
September, 2003 FDA 483 AbbVie Inc. - Form 483, 2003-09-26
January, 2006 FDA 483 Sage Products LLC - Form 483, 2006-01-26
February, 2004 EIR AbbVie Inc. - EIR, 2004-02-17
December, 2002 EIR AbbVie Inc. - EIR, 2002-12-12
April, 2002 FDA 483 Baxter Healthcare Corporation - Form 483, 2002-02-11
December, 2002 FDA 483 AbbVie Inc. - Form 483, 2002-12-12
September, 2003 FDA 483 Response Hospira, Inc. - Form 483R, 2003-09-18
April, 2002 FDA 483 Response Baxter Healthcare Corporation - Form 483R, 2002-04-12
February, 2003 EIR Hospira, Inc. - EIR, 2003-02-26

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more